Compare TMDX & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMDX | MAIN |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.3B |
| IPO Year | 2019 | 2013 |
| Metric | TMDX | MAIN |
|---|---|---|
| Price | $99.21 | $51.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $154.00 | $61.57 |
| AVG Volume (30 Days) | ★ 923.9K | 832.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 8.16% |
| EPS Growth | ★ 382.18 | N/A |
| EPS | ★ 4.87 | 3.95 |
| Revenue | ★ $605,494,000.00 | N/A |
| Revenue This Year | $24.51 | $6.27 |
| Revenue Next Year | $18.73 | $5.14 |
| P/E Ratio | $20.97 | ★ $13.39 |
| Revenue Growth | ★ 37.13 | N/A |
| 52 Week Low | $62.42 | $47.00 |
| 52 Week High | $156.00 | $67.77 |
| Indicator | TMDX | MAIN |
|---|---|---|
| Relative Strength Index (RSI) | 24.72 | 26.68 |
| Support Level | N/A | N/A |
| Resistance Level | $131.86 | $59.24 |
| Average True Range (ATR) | 5.48 | 1.36 |
| MACD | -2.58 | -0.22 |
| Stochastic Oscillator | 3.82 | 2.37 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.